Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Increased Plasma Kynurenic Acid Levels are Associated with Impaired Attention/Vigilance and Social Cognition in Patients with Schizophrenia</p>
Xingbing Huang, Wenhua Ding, Fengchun Wu, et al.
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 263-271
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations
Ather Muneer
Clinical Psychopharmacology and Neuroscience (2020) Vol. 18, Iss. 4, pp. 507-526
Open Access | Times Cited: 105
The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments
Abbas F. Almulla, Asara Vasupanrajit, Chavit Tunvirachaisakul, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 9, pp. 3679-3691
Open Access | Times Cited: 63
Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders
Katrien Skorobogatov, Livia De Picker, Robert Verkerk, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 61
Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis
Bing Cao, Yan Chen, Zhongyu Ren, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 123, pp. 203-214
Closed Access | Times Cited: 56
Use of the Chinese version of the MATRICS Consensus Cognitive Battery to assess cognitive functioning in individuals with high risk for psychosis, first-episode schizophrenia and chronic schizophrenia: a systematic review and meta-analysis
Bing Cai, Yikang Zhu, Dongyang Liu, et al.
The Lancet Regional Health - Western Pacific (2024) Vol. 45, pp. 101016-101016
Open Access | Times Cited: 5
Elevated serum kynurenic acid in individuals with first-episode psychosis and insufficient response to antipsychotics
Alexandros Hatzimanolis, Stefania Foteli, Lida‐Alkisti Xenaki, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Inulin alleviates chronic ketamine-induced impairments in memory and prepulse inhibition by regulating the gut microbiota, inflammation, and kynurenine pathway
Zhilong Xu, Haoyang Lu, Chen Hu, et al.
International Journal of Biological Macromolecules (2025) Vol. 294, pp. 139503-139503
Closed Access
Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: A meta-analysis
Manuel Morrens, Livia De Picker, Jarl K. Kampen, et al.
Schizophrenia Research (2020) Vol. 223, pp. 43-52
Closed Access | Times Cited: 29
Kynurenine pathway and autism spectrum phenotypes: an investigation among adults with autism spectrum disorder and their first-degree relatives
Barbara Carpita, Benedetta Nardi, Lionella Palego, et al.
CNS Spectrums (2022) Vol. 28, Iss. 3, pp. 374-385
Open Access | Times Cited: 18
Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies
Jacopo Sapienza, Marco Spangaro, Gilles J. Guillemin, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 273, Iss. 6, pp. 1317-1328
Closed Access | Times Cited: 17
The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies
Mehmet Enes Inam, Brisa S. Fernandes, Estela Salagre, et al.
Brazilian Journal of Psychiatry (2023)
Open Access | Times Cited: 6
Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology
Amira Ben Afia, Èlia Vila, Karina S. MacDowell, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 13
Tryptophan Derivatives by Saccharomyces cerevisiae EC1118: Evaluation, Optimization, and Production in a Soybean-Based Medium
Michele Dei, Ileana Vigentini, Sara Vitalini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 1, pp. 472-472
Open Access | Times Cited: 12
Gestational administration of Bifidobacterium dentium results in intergenerational modulation of inflammatory, metabolic, and social behavior
Jeffrey D. Galley, Mackenzie K King, Therese Rajasekera, et al.
Brain Behavior and Immunity (2024) Vol. 122, pp. 44-57
Closed Access | Times Cited: 1
Serum metabolic profile evidence for relationship between schizophrenia and depression: An untargeted metabolomics
Jing Zhang, Ruru Ren, Shuqin Ding, et al.
Biomedical Chromatography (2024)
Closed Access | Times Cited: 1
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability
Giacomo Mercuriali, Lorenzo Lodde, Pasquale Paribello, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Kynurenine pathway dysregulation as a mechanistic link between cognitive impairment and brain damage: Implications for multiple sclerosis
Marie Kupjetz, Tiffany Y. Wences Chirino, Niklas Joisten, et al.
Brain Research (2024), pp. 149415-149415
Open Access | Times Cited: 1
Searching for biomarkers in schizophrenia and psychosis: Case‐control study using capillary electrophoresis and liquid chromatography time‐of‐flight mass spectrometry and systematic review for biofluid metabolites
Saehyeon Kim, Kenji Okazaki, Ikuo Otsuka, et al.
Neuropsychopharmacology Reports (2021) Vol. 42, Iss. 1, pp. 42-51
Open Access | Times Cited: 10
Kynurenine, Kynurenic Acid, Quinolinic Acid and Interleukin-6 Levels in the Serum of Patients with Autism Spectrum Disorder
Veli Yıldırım, Şeref Şimşek, İhsan Çetin, et al.
Medicina (2023) Vol. 59, Iss. 11, pp. 1906-1906
Open Access | Times Cited: 3
Relationship between the tryptophan-kynurenine pathway and painful physical symptoms in patients with major depressive disorder
Yajun Yun, Qi Zhang, Wenxuan Zhao, et al.
Journal of Psychosomatic Research (2022) Vol. 163, pp. 111069-111069
Closed Access | Times Cited: 5
Association between plasma homocysteine levels and cognitive deficits in Han Chinese patients with schizophrenia across age groups
Sumiao Zhou, Yuanyuan Huang, Yangdong Feng, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 7
The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum and plasma compartments
Abbas F. Almulla, Asara Vasupanrajit, Chavit Tunvirachaisakul, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Increased plasma level of kynurenic acid in drug-free patients with first-episode schizophrenia compared to patients with chronic schizophrenia and healthy controls: preliminary data
Wenhua Ding, Fengchun Wu, Sumiao Zhou, et al.
Nordic Journal of Psychiatry (2021) Vol. 76, Iss. 6, pp. 451-456
Closed Access | Times Cited: 6
Markers of Inflammation, Energy and Glutamate Metabolism, and Antioxidant Defense in Patients with Adolescent Depression
S. A. Zozulya, О. К. Савушкина, T. A. Prokhorova, et al.
Neurochemical Journal (2024) Vol. 18, Iss. 1, pp. 13-21
Closed Access
Markers of inflammation, energy and glutamate metabolism, and antioxidant defense in patients with adolescent depression
S. A. Zozulya, О. К. Савушкина, T. A. Prokhorova, et al.
Нейрохимия (2024) Vol. 41, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top